Clinical Trial Update: Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) [Phase 3]

View source ↗

Summary

Phase 3 trial update on abaloparatide-SC in men with osteoporosis completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Osteoporosis
• Osteoporosis
• Osteoporosis of Vertebrae

Drugs mentioned

• abaloparatide-SC (abaloparatide)

Snippet

Sponsor: Radius Health, Inc. | Conditions: Osteoporosis, Osteoporosis, Age-Related | Phase 3 | Status: COMPLETED | Results posted: 2023-04-07